Search research articles
Contact Us
Filters
Showing results (101-110 of 356) with videos related to
Page
of 36
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
April 12, 2022
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
Giacomo Sgalla, Tonia Magrì, Marialessia Lerede, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 28, 2019
Statin Therapy and Lung Disorders
Pier-Valerio Mari, Francesco Lombardi, Maria Chiara Flore, et al.
Lung India : Official Organ of Indian Chest Society
|
January 28, 2015
Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
Zarir F Udwadia, Jai B Mullerpattan, Canchi Balakrishnan, et al.
Respiration; International Review of Thoracic Diseases
|
September 24, 2023
The Impact of Telemedicine during Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic and Future Perspectives: A Systematic Review
Giorgio Monteleone, Giovanni Terzulli, Francesca Cefaloni, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 23, 2011
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis?
Giovanni Ferrara, Shreemanta K Parida, Alimuddin Zumla, et al.
European Journal of Internal Medicine
|
June 26, 2012
The role of biomarkers in low respiratory tract infections
Francesco Blasi, Marialuisa Bocchino, Fabiano Di Marco, et al.
The European Respiratory Journal
|
August 2, 2014
A global registry for idiopathic pulmonary fibrosis: the time is now
Christopher J Ryerson, Tamera J Corte, Harold R Collard, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 16, 2015
Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?
Luca Richeldi, Florence Le Maulf, Rozsa Schlenker-Herceg, et al.
Recenti Progressi in Medicina
|
May 17, 2006
[New tools for a better diagnosis of latent tuberculosis infection]
Giovanni Ferrara, Monica Losi, Pietro Roversi, et al.
BMC Pulmonary Medicine
|
October 7, 2025
Long-term treatment with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a comparative, real-world cohort study
Francesca Lalla, Angelo Latella, Francesco Varone, et al.
Page
of 36
Search research articles
Search
Showing results (101-110 of 356) with videos related to
Sort By:
Page
of 36
American Journal of Respiratory and Critical Care Medicine
|
April 12, 2022
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
Giacomo Sgalla, Tonia Magrì, Marialessia Lerede, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 28, 2019
Statin Therapy and Lung Disorders
Pier-Valerio Mari, Francesco Lombardi, Maria Chiara Flore, et al.
Lung India : Official Organ of Indian Chest Society
|
January 28, 2015
Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
Zarir F Udwadia, Jai B Mullerpattan, Canchi Balakrishnan, et al.
Respiration; International Review of Thoracic Diseases
|
September 24, 2023
The Impact of Telemedicine during Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic and Future Perspectives: A Systematic Review
Giorgio Monteleone, Giovanni Terzulli, Francesca Cefaloni, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 23, 2011
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis?
Giovanni Ferrara, Shreemanta K Parida, Alimuddin Zumla, et al.
European Journal of Internal Medicine
|
June 26, 2012
The role of biomarkers in low respiratory tract infections
Francesco Blasi, Marialuisa Bocchino, Fabiano Di Marco, et al.
The European Respiratory Journal
|
August 2, 2014
A global registry for idiopathic pulmonary fibrosis: the time is now
Christopher J Ryerson, Tamera J Corte, Harold R Collard, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 16, 2015
Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?
Luca Richeldi, Florence Le Maulf, Rozsa Schlenker-Herceg, et al.
Recenti Progressi in Medicina
|
May 17, 2006
[New tools for a better diagnosis of latent tuberculosis infection]
Giovanni Ferrara, Monica Losi, Pietro Roversi, et al.
BMC Pulmonary Medicine
|
October 7, 2025
Long-term treatment with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a comparative, real-world cohort study
Francesca Lalla, Angelo Latella, Francesco Varone, et al.
Page
of 36